Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine-induced anemia and in bone marrow endothelial cells

Cytokine

Volumn 18, Issue 1, 2002, Pages 51-60

  Difalco, Marcos R ^a   Congote, Luis Fernando ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

AIDS; Endothelial erythroid stimulating factors; Hypoxia; Inhibitors; TNF family

Indexed keywords

ANTIMETABOLITE; ERYTHROPOIETIN; HYBRID PROTEIN; INTERLEUKIN 3; SOMATOMEDIN B; THYMIDINE; ZIDOVUDINE;

ANEMIA; ANIMAL; ARTICLE; BONE MARROW CELL; CATTLE; CELL CULTURE; CELL STRAIN HL 60; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DOSE RESPONSE; ENDOTHELIUM; HUMAN; LEUKEMIA CELL LINE; LIVER; METABOLISM; MOUSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL FUNCTION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; ERYTHROID CELL; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT; ULTRACENTRIFUGATION; ULTRAFILTRATION;

ANEMIA; ANIMALS; ANTIMETABOLITES; BONE MARROW CELLS; CATTLE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM; ERYTHROPOIETIN; HL-60 CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; INTERLEUKIN-3; JURKAT CELLS; LIVER; MICE; RECOMBINANT FUSION PROTEINS; THYMIDINE; ZIDOVUDINE;

ANIMALIA; BOVINAE;

EID: 0036020272     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2002.1029     Document Type: Article

References (40)

1. In vivo e3ects of interleukin 3 in HIV type 1-infected patients with cytopenia
2. Preparation of a recombinant chimera of insulin-like growth factor II and interleukin 3 with high proliferative potency for hematopoietic cells
3. Efficacy of an insulin-like growth factor-interleukin-3 fusion protein in reversing the hematopoietic toxicity associated with azidothymidine in mice
4. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hemato-poietic progenitors
5. Inhibitory effects of zidovudine in erythroid progenitor cells. Reversal with a combination of erythropoietin and interleukin-3
6. In vitro differentiation of endothelial cells from AC133-positive progenitor cells
7. Failure of blood-island formation and vasculogenesis in Flk-1-6deficient mice
8. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis
9. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells
10. Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells
11. Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues
12. Role of adenosine in the hypoxic induction of vascular endothelial growth factor in porcine brain derived microvascular endothelial cells
13. Barbiturates decrease the expression of vascular endothelial growth factor in hypoxic cultures of porcine brain derived microvascular endothelial cells
14. Regulation of hematopoiesis by microvascular endothelium
15. Soluble factor(s) alone produced by primary porcine microvascular endothelial cells support the proliferation and differentiation of human CD34+ hematopoietic progenitor cells with a high replating potential
16. CD34+ endothelial cell lines derived from murine yolk sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors
17. Bovine fetal-liver stromal cells support erythroid colony formation: Enhancement by insulin-like growth factor II
18. BMEC-1: A human bone marrow microvascular endothelial cell line with primary cell characteristics
19. Effects of perinatal zidovudine on hematopoiesis: A comparison of effects on progenitors from human fetuses versus mothers
20. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis
21. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles
22. Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles
23. Assay for thymidine incorporation into anchorage dependent and independent cells without filtration or cell harvesting
24. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia
25. Therapeutic value of interleukin-3 given alone or in combination with other cytokines
26. In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine
27. Limited erythropoietic response to combined treatment with recombinant human interleukin 3 and erythropoietin in myelodysplastic syndrome
28. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone
29. Synergism of hemopoietic growth factors on endothelial cell proliferation
30. Hypoxia Inhibition of Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
31. Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor
32. Functional characterization of the insulin-like growth factor I receptor on Jurkat T cells
33. Insulin-like growth factor 1 and insulin inhibit HIV type 1 replication in cultured cells
34. C-Myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNF alpha-treated HL-60 cells
35. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha
36. Changes of phospholipase D activity in TNF-alpha and anti-Fas/Apo1 monoclonal antibody induced apoptosis in HL-60 and A20 cells
37. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1
38. Erythropoietin-dependent suppression of the expression of the beta subunits of the interleukin-3 receptor during erythroid di3erentiation
39. HIV-1 gp120-and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases
40. Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120